Eurofins Scientific SE (FRA:ESF0) Research & Development: €0 Mil (TTM As of Dec. 2025)


FRA:ESF0 Eurofins Scientific SE FRA:ESF0
87 GF Score
Price €64.88
GF Value €66.54
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Research & Development?

Eurofins Scientific SE FRA:ESF0 +3.31% 87 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates FRA:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.54 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Eurofins Scientific SE's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Eurofins Scientific SE  (FRA:ESF0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Eurofins Scientific SE Research & Development Related Terms

Eurofins Scientific SE Research & Development Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Research & Development Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eurofins Scientific SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:ESF0
87GF Score
Eurofins Scientific SE FRA:ESF0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Eurofins Scientific SE (FRA:ESF0) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Research & Development too high?
Eurofins Scientific SE's current Research & Development is €0 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Research & Development compare to TMO and DHR?
Eurofins Scientific SE's Research & Development of €0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (FRA:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.54, compared to a current price of €64.88 — trading 2.5% below its estimated fair value. The current Research & Development is €0 Mil. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Eurofins Scientific SE (FRA:ESF0), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (FRA:ESF0) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be undervalued. The current stock price of €64.88 is trading 2.5% below its estimated GF Value™ of €66.54. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for FRA:ESF0:

  • Research & Development: €0 Mil
  • GF Value™: €66.54 vs. price of €64.88 (2.5% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
87GF Score

Get the complete analysis for FRA:ESF0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.88
Price
€66.54
GF Value